Analysts Set Envista Holdings Co. (NYSE:NVST) Price Target at $20.18

Envista Holdings Co. (NYSE:NVSTGet Free Report) has earned an average recommendation of “Hold” from the fifteen ratings firms that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $20.18.

Several analysts have issued reports on NVST shares. Morgan Stanley cut their price objective on Envista from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 6th. JPMorgan Chase & Co. lowered their target price on Envista from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Thursday, March 6th. Piper Sandler upped their target price on Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, February 3rd. Jefferies Financial Group upped their target price on Envista from $20.00 to $22.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Finally, Mizuho began coverage on Envista in a report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 target price for the company.

Check Out Our Latest Report on Envista

Hedge Funds Weigh In On Envista

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NVST. Huntington National Bank boosted its stake in Envista by 97.8% during the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after purchasing an additional 949 shares in the last quarter. Venturi Wealth Management LLC lifted its position in shares of Envista by 528.4% during the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock valued at $38,000 after acquiring an additional 1,638 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Envista by 30.5% during the 4th quarter. GAMMA Investing LLC now owns 2,304 shares of the company’s stock valued at $44,000 after acquiring an additional 538 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Envista during the 4th quarter valued at $53,000. Finally, Mitsubishi UFJ Trust & Banking Corp acquired a new stake in shares of Envista during the 4th quarter valued at $86,000.

Envista Trading Up 0.7 %

Shares of NYSE NVST opened at $17.02 on Friday. The stock’s 50 day moving average price is $19.85 and its two-hundred day moving average price is $19.61. Envista has a 52-week low of $15.15 and a 52-week high of $23.00. The stock has a market capitalization of $2.93 billion, a P/E ratio of -2.62, a PEG ratio of 1.27 and a beta of 1.33. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44.

Envista (NYSE:NVSTGet Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, analysts anticipate that Envista will post 1 earnings per share for the current fiscal year.

Envista Company Profile

(Get Free Report

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Further Reading

Analyst Recommendations for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.